This also indicated that AFP fragment could synergize with sorafenib to block the important pathways that involve in tumour growth, proliferation and metastasis, result in inhibit angiogenesis, and promote apoptosis in HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.